S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
NYSE:TFX

Teleflex - TFX Stock Forecast, Price & News

$241.34
+0.54 (+0.22%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$240.62
$245.78
50-Day Range
$222.88
$262.22
52-Week Range
$182.65
$356.72
Volume
343,013 shs
Average Volume
354,718 shs
Market Capitalization
$11.33 billion
P/E Ratio
31.42
Dividend Yield
0.56%
Price Target
$271.69

Teleflex MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
12.6% Upside
$271.69 Price Target
Short Interest
Healthy
2.26% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.50mentions of Teleflex in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.01%
From $13.29 to $14.62 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.69 out of 5 stars

Medical Sector

65th out of 986 stocks

Surgical & Medical Instruments Industry

7th out of 100 stocks


TFX stock logo

About Teleflex (NYSE:TFX) Stock

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

Analysts Set Teleflex Incorporated (NYSE:TFX) PT at $271.69
Teleflex (NYSE:TFX) Upgraded by StockNews.com to "Buy"
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Teleflex Full Year 2022 Earnings: EPS Misses Expectations
Teleflex (TFX) Surpasses Q4 Earnings Estimates
Return Trends At Teleflex (NYSE:TFX) Aren't Appealing
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Company Calendar

Last Earnings
2/23/2023
Ex-Dividend for 3/15 Dividend
3/02/2023
Dividend Payable
3/15/2023
Today
3/23/2023
Next Earnings (Estimated)
4/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
15,500
Year Founded
1943

Price Target and Rating

Average Stock Price Forecast
$271.69
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+12.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
12 Analysts

Profitability

Net Income
$363.14 million
Pretax Margin
15.98%

Debt

Sales & Book Value

Annual Sales
$2.79 billion
Cash Flow
$18.48 per share
Book Value
$85.74 per share

Miscellaneous

Free Float
46,343,000
Market Cap
$11.33 billion
Optionable
Optionable
Beta
0.98

Social Links


Key Executives

  • Liam J. KellyLiam J. Kelly
    Chairman, President & Chief Executive Officer
  • Thomas E. Powell
    Chief Financial Officer & Executive Vice President
  • Justin McMurray
    VP-Global Strategic Research & Development
  • Timothy F. Duffy
    Chief Information Officer & Vice President
  • Michelle Fox
    Chief Medical Officer & Vice President













TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TFX shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price forecast for 2023?

12 Wall Street research analysts have issued twelve-month price targets for Teleflex's shares. Their TFX share price forecasts range from $210.00 to $330.00. On average, they expect the company's share price to reach $271.69 in the next twelve months. This suggests a possible upside of 12.6% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2023?

Teleflex's stock was trading at $249.63 on January 1st, 2023. Since then, TFX shares have decreased by 3.3% and is now trading at $241.34.
View the best growth stocks for 2023 here
.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our TFX earnings forecast
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) posted its quarterly earnings results on Thursday, February, 23rd. The medical technology company reported $3.52 earnings per share for the quarter, beating analysts' consensus estimates of $3.44 by $0.08. The medical technology company earned $758 million during the quarter, compared to the consensus estimate of $760.29 million. Teleflex had a trailing twelve-month return on equity of 15.87% and a net margin of 13.01%. The business's revenue for the quarter was down .5% on a year-over-year basis. During the same period last year, the company earned $3.60 earnings per share.
Read the conference call transcript
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, February 23rd. Stockholders of record on Friday, March 3rd will be paid a dividend of $0.34 per share on Wednesday, March 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date is Thursday, March 2nd.
Read our dividend analysis for TFX
.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.57%. The dividend payout ratio is 17.71%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.30% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY23 earnings guidance on Thursday, February, 23rd. The company provided EPS guidance of $13.00-13.60 for the period, compared to the consensus estimate of $13.49. The company issued revenue guidance of ~$2.91-2.95 billion, compared to the consensus revenue estimate of $2.92 billion.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of retail and institutional investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (18.40%), Morgan Stanley (5.74%), Price T Rowe Associates Inc. MD (2.60%), Geode Capital Management LLC (2.02%), Allspring Global Investments Holdings LLC (1.71%) and Bessemer Group Inc. (1.13%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, John Deren, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $241.34.

How much money does Teleflex make?

Teleflex (NYSE:TFX) has a market capitalization of $11.33 billion and generates $2.79 billion in revenue each year. The medical technology company earns $363.14 million in net income (profit) each year or $7.68 on an earnings per share basis.

How many employees does Teleflex have?

The company employs 15,500 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 3/23/2023 by MarketBeat.com Staff